Home LiteratureArticle Details
PMID: 19564254 Published · ppublish English Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

Pediatrics ·Vol. 124 ·No. 1 ·2009-07-00 ·Pages e1-11

Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA

Abstract

The goals were to assess serial changes in Streptococcus pneumoniae serotypes and antibiotic resistance in young children and to evaluate whether risk factors for carriage have been altered by heptavalent pneumococcal conjugate vaccine (PCV7). Nasopharyngeal specimens and questionnaire/medical record data were obtained from children 3 months to <7 years of age in primary care practices in 16 Massachusetts communities during the winter seasons of 2000-2001 and 2003-2004 and in 8 communities in 2006-2007. Antimicrobial susceptibility testing and serotyping were performed with S pneumoniae isolates. We collected 678, 988, and 972 specimens during the sampling periods in 2000-2001, 2003-2004, and 2006-2007, respectively. Carriage of non-PCV7 serotypes increased from 15% to 19% and 29% (P < .001), with vaccine serotypes decreasing to 3% of carried serotypes in 2006-2007. The relative contribution of several non-PCV7 serotypes, including 19A, 35B, and 23A, increased across sampling periods. By 2007, commonly carried serotypes included 19A (16%), 6A (12%), 15B/C (11%), 35B (9%), and 11A (8%), and high-prevalence serotypes seemed to have greater proportions of penicillin nonsusceptibility. In multivariate models, common predictors of pneumococcal carriage, such as child care attendance, upper respiratory tract infection, and the presence of young siblings, persisted. The virtual disappearance of vaccine serotypes in S pneumoniae carriage has occurred in young children, with rapid replacement with penicillin-nonsusceptible nonvaccine serotypes, particularly 19A and 35B. Except for the age group at highest risk, previous predictors of carriage, such as child care attendance and the presence of young siblings, have not been changed by the vaccine.

MeSH Terms
Carrier State/epidemiology Child Child Day Care Centers Child, Preschool Drug Resistance, Multiple, Bacterial Family Health Heptavalent Pneumococcal Conjugate Vaccine Humans Infant Massachusetts Microbial Sensitivity Tests Monte Carlo Method Multivariate Analysis Nasopharynx/microbiology Penicillin Resistance Pneumococcal Infections/epidemiology,prevention & control Pneumococcal Vaccines Prevalence Serotyping Streptococcus pneumoniae/classification,isolation & purification Vaccines, Conjugate
Chemicals
Heptavalent Pneumococcal Conjugate Vaccine Pneumococcal Vaccines Vaccines, Conjugate
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Huang Susan S
Division of Infectious Diseases, School of Medicine, University of California, Irvine, Orange, CA 92868, USA. [email protected]
Hinrichsen Virginia L
Stevenson Abbie E
Rifas-Shiman Sheryl L
Kleinman Ken
Pelton Stephen I
Lipsitch Marc
Hanage William P
Lee Grace M
Finkelstein Jonathan A
References (40)
40 references, click to expand
  1. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
    Pediatrics. 2003 Oct;112(4):862-9 PMID: 14523178
  2. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience.
    J Clin Microbiol. 2008 Mar;46(3):982-90 PMID: 18234877
  3. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era.
    J Infect Dis. 2007 Feb 1;195(3):347-52 PMID: 17205472
  4. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Clin Infect Dis. 2005 Jul 1;41(1):21-9 PMID: 15937758
  5. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization.
    Ann Intern Med. 2006 Jan 3;144(1):1-9 PMID: 16389249
  6. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?
    Clin Infect Dis. 2008 May 1;46(9):1346-52 PMID: 18419434
  7. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    J Infect Dis. 2007 Nov 1;196(9):1346-54 PMID: 17922399
  8. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Clin Infect Dis. 2008 Jan 15;46(2):174-82 PMID: 18171247
  9. The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis.
    Mol Biol Evol. 2005 Mar;22(3):562-9 PMID: 15537808
  10. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
    J Infect Dis. 1996 Dec;174(6):1271-8 PMID: 8940218
  11. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    J Infect Dis. 2005 Dec 1;192(11):1988-95 PMID: 16267772
  12. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts.
    Pediatrics. 2008 Jan;121(1):e15-23 PMID: 18166533
  13. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Pediatr Infect Dis J. 2004 Jun;23(6):485-9 PMID: 15194827
  14. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.
    PLoS Pathog. 2007 Nov;3(11):e168 PMID: 18020702
  15. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
    JAMA. 2006 Apr 12;295(14):1668-74 PMID: 16609088
  16. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8 PMID: 18272956
  17. Replacement pneumococcal disease in perspective.
    Clin Infect Dis. 2008 May 1;46(9):1353-5 PMID: 18419435
  18. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.
    Pediatr Infect Dis J. 2005 Jan;24(1):17-23 PMID: 15665705
  19. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.
    J Infect Dis. 1999 Oct;180(4):1171-6 PMID: 10479145
  20. Does it really take longer not to prescribe antibiotics for viral respiratory tract infections in children?
    Ambul Pediatr. 2006 May-Jun;6(3):152-6 PMID: 16713933
  21. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
    Pediatr Infect Dis J. 2008 Apr;27(4):335-40 PMID: 18316986
  22. Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm.
    Pediatr Infect Dis J. 2006 Oct;25(10):981-6 PMID: 17006311
  23. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study.
    BMJ. 2007 Sep 1;335(7617):429 PMID: 17656505
  24. Antibiotic prescribing by primary care physicians for children with upper respiratory tract infections.
    Arch Pediatr Adolesc Med. 2002 Nov;156(11):1114-9 PMID: 12413339
  25. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
    JAMA. 2005 Oct 26;294(16):2043-51 PMID: 16249418
  26. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine.
    J Infect Dis. 2009 Feb 1;199(3):320-5 PMID: 19099489
  27. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pediatr Infect Dis J. 2007 Jun;26(6):468-72 PMID: 17529860
  28. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae.
    Clin Infect Dis. 2005 Oct 1;41(7):930-8 PMID: 16142656
  29. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers.
    Pediatr Infect Dis J. 2003 Jun;22(6):532-40 PMID: 12799510
  30. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.
    JAMA. 2007 Oct 17;298(15):1772-8 PMID: 17940232
  31. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
    N Engl J Med. 2003 May 1;348(18):1737-46 PMID: 12724479
  32. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    MMWR Morb Mortal Wkly Rep. 2007 Oct 19;56(41):1077-80 PMID: 17947966
  33. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pediatr Infect Dis J. 2007 Oct;26(10 Suppl):S12-6 PMID: 18049375
  34. Trends in antimicrobial prescribing rates for children and adolescents.
    JAMA. 2002 Jun 19;287(23):3096-102 PMID: 12069672
  35. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.
    JAMA. 2007 Apr 25;297(16):1784-92 PMID: 17456820
  36. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
    MMWR Morb Mortal Wkly Rep. 2005 Sep 16;54(36):893-7 PMID: 16163262
  37. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.
    Pediatrics. 2005 Sep;116(3):e408-13 PMID: 16140686
  38. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life.
    Clin Infect Dis. 2004 Oct 1;39(7):930-8 PMID: 15472842
  39. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.
    Pediatr Infect Dis J. 2004 Nov;23(11):1015-22 PMID: 15545856
  40. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    N Engl J Med. 2001 Feb 8;344(6):403-9 PMID: 11172176
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
1098-4275
Published
2009-07-00
Pages
e1-11
Language
English
Region
United States
NLM ID
0376422
PMCID
PMC2782668
Subset
IM
Grants
NIAID NIH HHS · R01 AI066304 · United States
NIAID NIH HHS · R01 AI066304-01A1 · United States
NIAID NIH HHS · AI066304 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]